Sanofi-Aventis Enters First R&D Pact In India, For Glenmark's Pain Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Lead candidate, GRC 15300, is in Phase I for diabetic neuropathic pain and osteoarthritric pain.